Prudential Financial Inc vs Revolution Medicines Inc. Common Stock — how do they compare? Prudential Financial Inc trades at $111.72 (market cap $39.17B), while Revolution Medicines Inc. Common Stock trades at $186.71 (market cap $40.32B). The key difference: Prudential Financial Inc and Revolution Medicines Inc. Common Stock are close in size by market cap, and Prudential Financial Inc pays a 4.93% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Prudential Financial Inc for 145 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PRU | RVMD | |
|---|---|---|
Market Cap | $39.17B | $40.32B |
Volume | 1,436,917 | 4,855,734 |
Sector | Financials | Health |
52-Week High | $125.13 | $221.15 |
52-Week Low | $92.00 | $47.50 |
Typical Hold Time | 145 Days | 0 Days |
Enterprise Value | $67.95B | $37.02B |
Dividend Yield | 4.93% | — |
Signals from Pluang's Aura AI — not financial advice
Prudential Financial (PRU) trades at $112.36, down 1.04% with bearish technical signals despite recent earnings beats. The stock shows attractive valuation metrics with P/E of 10.29 and P/S of 0.61, while maintaining solid profitability with 6.04% net margin and 12.46% ROE. Recent strategic moves include exiting emerging markets with Alexforbes sale and rebranding to Prudential Wealth Advisors, reflecting focus on core operations.
While valuation appears compelling and higher interest rates benefit investment income, analyst sentiment remains cautious with 67.57% hold ratings. The stock faces execution risks from strategic restructuring and competitive pressures in insurance markets. Current price near consensus target of $105.67 suggests limited near-term upside despite fundamental strength.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →